More radiation may decrease breast cancer recurrence risk in some patients
the ONA take:
After conservation surgery, some women who undergo additional radiation given to the lymph nodes along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence, according to a study in the New England Journal of Medicine.
Researchers led by Tim Whelan, MD, of McMaster University’s Michael G. DeGroote School of Medicine looked at women with axillary node-positive or high-risk node-negative breast cancer in order to determine whether adding regional node irradiation to whole-breast irradiation proved more beneficial than whole-breast irradiation alone.
More than 1,800 patients were included in the 14-year study as part of NCIC Clinical Trials Group at Queen’s University in Ontario.
They found that additional radiation to the surrounding lymph nodes reduced risk of subsequence recurrence both locally and at sites distant from the breast.
“This study is important because it shows that additional radiation to the surrounding lymph nodes provides added benefit to women, particularly those with involvement of the lymph nodes in the axilla,” Dr. Whelan said. “Further research is necessary to determine which women are most likely to benefit and who may avoid the additional radiation.”
Some women who undergo additional radiation along with whole-breast irradiation may be at a reduced risk of breast cancer recurrence.
- Study Identifies Factors Associated With Hearing Loss in Polycythemia Vera
- Ezh2 Inhibitors May Offer Cure for Chronic Myelogenous Leukemia
- Ruxolitinib: A Targeted Treatment Option for Patients with Polycythemia Vera
- Incontinence Affects QOL for Survivors of Gynecologic Cancers
- Robotic Surgery Provides Good Outcomes and Survival in Oropharyngeal Cancer
- Overall Benefits of Vaporized Nicotine Products Outweigh Harms, Says International Panel of Experts
- Sugar and Cancer: Mitigating the Affects of Diet on Cancer
- Nurse Residency Programs Can Impact Oncology Nursing Practice, Outcomes
- Tumor Markers (Fact Sheet)
- Implementing a Distress Screening Process for Cancer Patients
- SBRT Improves Overall and Disease-Specific Survival in Stage I NSCLC
- Patients Receiving RT in APBI Facilities Despite Eligibility for Observation
- Prolonged Imatinib Therapy Improves Likelihood of Deeper Molecular Response
- ASCO, ASTRO Issue Guideline Update for Postmastectomy RT
- Study Assesses Efficacy of Ramucirumab in HCC by Child-Pugh Score
Sign Up for Free e-newsletters
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|